MSF's publications are an expression of our belief in the principle of témoignage, or bearing witness, and the belief that we are accountable to those we work for and with. Sharing news about our activities and reflecting on them, offering critiques when necessary, are therefore crucial aspects of our work.

View and download these publications below.

To view the U.S. Annual Reports or International Activity Reports, please visit the Annual Reports page.

Topic

MSF calls on the stakeholders of the Global Fund to convene an emergency donor conference and to open a new early funding window to ensure that the Fund is fully functional in 2012.

More >

While international attention focuses on Myanmar, a health crisis in the country looms large. An estimated 85,000 people infected with HIV in Myanmar are not receiving lifesaving treatment. 

More >

Learn how a free trade agreement between the European Union and India could restrict access to affordable medicines for millions of people with HIV/AIDS and other diseases and conditions.

More >

The cancelation of Round 11 of the Global Fund to Fight AIDS, Tuberculosis, and Malaria undermines the significant progress that has been made in the uphill battles against these deadly diseases.

More >

I am writing on behalf of MSF to express our disappointment that J&J has not yet placed any patent into the Medicines Patent Pool and that it has announced in a recent letter to the Medicines Patent Pool that it is not ready to engage in formal negotiations.

More >

The crucial role India plays in supplying the developing world with affordable quality medicines is being threatened.

More >

MSF Teleconference on Innovative Financing Mechanisms for Global Health, conducted September 20, 2010

More >

My name is Dr. Tido von Schoen-Angerer and I am speaking on behalf of Médecins Sans Frontières. Thank you for the opportunity to address this important gathering.

In 2000, I was working in one of MSF’s AIDS projects. Our response to the pandemic was one based on a simple medical decision: faced with the urgency of patients dying, the only acceptable response was to treat. This was an ethical imperative, to treat, regardless of the difficulties.

More >

Press teleconference on Thailand's compulsory licensing of an HIV/AIDS treatment, Abbott's response, and the coming crisis in availablity of second-line HIV drugs in developing countries.

More >

In the past 5 years, considerable progress has been made in scaling-up access to antiretroviral therapy.  Today, 1.3 million people are receiving treatment.  But a huge amount remains to be done.

More >

Pages